LIBRARY
HEADlines
Issue 138: ChatGPT in education – boon or bane?
February 2023
Issue 137: Will ChatGPT become your next doctor?
January 2023
Issue 136: Rethinking the university route
January 2023
Issue 130: Inequity and learning loss in a post-COVID world
September 2022
Issue 129: Healthy gut, healthy brain
September 2022
Issue 128: Literacy after the pandemic
September 2022
Issue 127: Boost your memory with a pulse of electricity
September 2022
Issue 125: Can science stop ageing?
August 2022
Issue 122: Changing how we teach
July 2022
Issue 110: World Health Day 2022
April 2022
Issue 109: Learning beyond grades
April 2022
A patient in New Zealand became the first person to receive a gene-editing serum to permanently lower levels of ‘bad’ LDL cholesterol, a major cause of heart disease worldwide. The procedure involved injecting an improved version of the gene-editing tool, CRISPR, to turn off a ‘bad’ gene by replacing a single letter in the liver DNA.